Effect of Daily Intake of SATIOSTAT Over 6 Weeks on Weight Loss, Glucose Tolerance, Gastrointestinal Tolerance and Gut Microbiota.
Clinical trial NCT02956369 · COMPLETED
Trial details
- NCT number
- NCT02956369
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-16
- Primary completion
- 2019-05-06
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.